PortfoliosLab logoPortfoliosLab logo
ARM vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ARM vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arm Holdings plc American Depositary Shares (ARM) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARM achieves a 248.38% return, which is significantly higher than NVO's -10.74% return.


ARM

1D
11.27%
1M
66.66%
YTD
248.38%
6M
190.94%
1Y
180.94%
3Y*
5Y*
10Y*

NVO

1D
-0.18%
1M
-4.19%
YTD
-10.74%
6M
-9.50%
1Y
-42.47%
3Y*
-15.59%
5Y*
2.92%
10Y*
7.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARM vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023
ARM
Arm Holdings plc American Depositary Shares
248.38%-11.39%64.16%33.95%
NVO
Novo Nordisk A/S
-10.74%-39.22%-15.93%7.41%

Correlation

The correlation between ARM and NVO is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Sep 14, 2023

0.20

Fundamentals

Market Cap

ARM:

$406.71B

NVO:

$195.21B

EPS

ARM:

$0.85

NVO:

DKK 27.42

PE Ratio

ARM:

449.79

NVO:

10.34

PEG Ratio

ARM:

15.43

NVO:

0.44

PS Ratio

ARM:

82.64

NVO:

3.85

PB Ratio

ARM:

49.08

NVO:

6.21

Total Revenue (TTM)

ARM:

$4.92B

NVO:

DKK 327.80B

Gross Profit (TTM)

ARM:

$4.66B

NVO:

DKK 268.30B

EBITDA (TTM)

ARM:

$1.37B

NVO:

DKK 181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARM vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARM
ARM Risk / Return Rank: 9090
Overall Rank
ARM Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
ARM Sortino Ratio Rank: 9191
Sortino Ratio Rank
ARM Omega Ratio Rank: 9090
Omega Ratio Rank
ARM Calmar Ratio Rank: 9090
Calmar Ratio Rank
ARM Martin Ratio Rank: 8686
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1212
Overall Rank
NVO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1212
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1212
Calmar Ratio Rank
NVO Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARM vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arm Holdings plc American Depositary Shares (ARM) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ARMNVODifference
Sharpe ratioReturn per unit of total volatility

+3.39

Sortino ratioReturn per unit of downside risk

+4.21

Omega ratioGain probability vs. loss probability

1.40

0.85

+0.55

Calmar ratioReturn relative to maximum drawdown

4.24

-0.80

+5.04

Martin ratioReturn relative to average drawdown

8.33

-1.18

+9.51

ARM vs. NVO - Sharpe Ratio Comparison

The current ARM Sharpe Ratio is 2.55, which is higher than the NVO Sharpe Ratio of -0.84. The chart below compares the historical Sharpe Ratios of ARM and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ARM vs. NVO - Drawdown Comparison

The maximum ARM drawdown since its inception was -53.97%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for ARM and NVO.


Loading charts...

Drawdown Indicators


ARMNVODifference

Max Drawdown

Largest peak-to-trough decline

-53.97%

-74.70%

+20.73%

Max Drawdown (1Y)

Largest decline over 1 year

-41.47%

-54.34%

+12.87%

Max Drawdown (3Y)

Largest decline over 3 years

-74.70%

Max Drawdown (5Y)

Largest decline over 5 years

-74.70%

Max Drawdown (10Y)

Largest decline over 10 years

-74.70%

Current Drawdown

Current decline from peak

-7.53%

-68.11%

+60.58%

Average Drawdown

Average peak-to-trough decline

-21.33%

-17.79%

-3.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.07%

37.62%

-16.55%

Volatility

ARM vs. NVO - Volatility Comparison

Arm Holdings plc American Depositary Shares (ARM) has a higher volatility of 37.22% compared to Novo Nordisk A/S (NVO) at 10.68%. This indicates that ARM's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ARMNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

37.22%

10.68%

+26.54%

Volatility (6M)

Calculated over the trailing 6-month period

58.04%

38.04%

+20.00%

Volatility (1Y)

Calculated over the trailing 1-year period

68.92%

51.88%

+17.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

76.58%

38.33%

+38.25%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

76.58%

32.56%

+44.02%

Dividends

ARM vs. NVO - Dividend Comparison

ARM has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.11%.


PositionTTM20252024202320222021202020192018201720162015
ARM
Arm Holdings plc American Depositary Shares
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
4.11%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Financials

ARM vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Arm Holdings plc American Depositary Shares and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
1.49B
96.82B
(ARM) Total Revenue
(NVO) Total Revenue
Please note, different currencies. ARM values in USD, NVO values in DKK

ARM vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Arm Holdings plc American Depositary Shares and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

80.0%85.0%90.0%95.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
93.1%
86.0%
Portfolio components
ARM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Arm Holdings plc American Depositary Shares reported a gross profit of 1.39B and revenue of 1.49B. Therefore, the gross margin over that period was 93.1%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

ARM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Arm Holdings plc American Depositary Shares reported an operating income of 440.00M and revenue of 1.49B, resulting in an operating margin of 29.5%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

ARM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Arm Holdings plc American Depositary Shares reported a net income of 313.00M and revenue of 1.49B, resulting in a net margin of 21.0%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.


Frequently Asked Questions


ARM and NVO have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARM has higher volatility (37.22%) compared to NVO (10.68%). In terms of maximum drawdown, ARM dropped -53.97% vs NVO's -74.70%.

ARM currently has the higher Sharpe Ratio (2.55 vs -0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ARM and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer